Skip to content

A clinical study to know the benefit of Prabhakar vati and Sarpagandha vati in shonita dusti with reference to essential hypertension

A comparative clinical to evaluate the efficacy of prabhakara vati with sarpagandha vati in shonita dusti with special reference to essential hypertension - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075322
Enrollment
40
Registered
2024-10-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I00-I99- Diseases of the circulatory system

Interventions

None listed

Sponsors

Jyoti Ashok Belavi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with samanya lakshana of Shonita dusti.

Exclusion criteria

Exclusion criteria: Patients with history of cerebrovascular accident, chronic kidney disease. diabetic mellitus other systemic,Metabolic disorders. Patients having secondary hypertension. Patients with history of Disorders related with haemopoietic system like Leukemia Hemophilia Unconscious, Coma patient, and Patients who are suffering with Gastro-intestinal bleeding disorders.

Design outcomes

Primary

MeasureTime frame
Headache reducedTimepoint: After 14 days

Secondary

MeasureTime frame
Improved in generalised weakness and daily activitiesTimepoint: After 21 days of treatment

Countries

India

Contacts

Public ContactJyoti Ashok Belavi

Shri Shivayoogeeshwar Rural Ayurvedic College Hospital Inchal

belavijyoti@gmail.com8073224705

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026